TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+9.85%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.6B
AUM Growth
+$2.6B
(+9.1%)
Cap. Flow
+$68.9M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
41.87%
Holding
156
New
13
Increased
21
Reduced
25
Closed
10
Top Buys
| 1 |
Merck
MRK
|
$28M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$21.3M |
| 3 |
Abbott
ABT
|
$18M |
| 4 |
Eli Lilly
LLY
|
$17M |
| 5 |
CVS Health
CVS
|
$16.7M |
Top Sells
| 1 |
Illumina
ILMN
|
$22.7M |
| 2 |
HCA Healthcare
HCA
|
$18.1M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$15.9M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$15.5M |
| 5 |
STJ
St Jude Medical
STJ
|
$12.4M |
Sector Composition
| 1 | Healthcare | 91.79% |
| 2 | Real Estate | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alkermes
ALKS
$4.95B
| $27.4M | 1.05% |
581,944
-111,900
| -16% | -$5.26M |
|
27
Cencora
COR
$57.2B
| $26.7M | 1.03% |
330,687
-45,813
| -12% | -$3.7M |
|
28
Molina Healthcare
MOH
$9.6B
| $23.5M | 0.9% |
402,541
-135,360
| -25% | -$7.89M |
|
29
Agilent Technologies
A
$35.5B
| $21.7M | 0.83% |
459,950
-35,500
| -7% | -$1.67M |
|
|
MDCO
30
DELISTED
Medicines Co
MDCO
| $21.3M | 0.82% |
564,438
-139,800
| -20% | -$5.28M |
|
31
Novartis
NVS
$248B
| $19.6M | 0.76% |
248,800
+78,700
| +46% | +$6.21M |
|
|
ENDP
32
DELISTED
Endo International plc
ENDP
| $18.4M | 0.71% |
914,548
+628,200
| +219% | +$12.7M |
|
|
CPHD
33
DELISTED
Cepheid Inc
CPHD
| $17.6M | 0.68% |
333,590
| – | – |
|
34
Puma Biotechnology
PBYI
$258M
| $17.4M | 0.67% |
260,200
| – | – |
|
35
Centene
CNC
$14.8B
| $17.2M | 0.66% |
256,500
+136,500
| +114% | +$9.14M |
|
36
iShares Biotechnology ETF
IBB
$5.68B
| $16.7M | 0.64% |
57,670
| – | – |
|
37
Universal Health Services
UHS
$11.6B
| $16.6M | 0.64% |
134,680
| – | – |
|
38
Alnylam Pharmaceuticals
ALNY
$58.6B
| $16.5M | 0.64% |
243,995
| – | – |
|
39
GSK
GSK
$79.3B
| $15.5M | 0.6% |
359,000
-75,200
| -17% | -$3.24M |
|
40
AstraZeneca
AZN
$255B
| $15.2M | 0.59% |
463,800
-110,200
| -19% | -$3.62M |
|
41
Idexx Laboratories
IDXX
$50.7B
| $14.9M | 0.57% |
132,352
| – | – |
|
42
Omega Healthcare
OHI
$12.5B
| $14.6M | 0.56% |
413,116
| – | – |
|
43
Thermo Fisher Scientific
TMO
$183B
| $13.7M | 0.53% |
86,395
| – | – |
|
|
HZNP
44
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $13.6M | 0.52% |
749,900
| – | – |
|
|
WELL.PRI
45
DELISTED
Welltower Inc.
WELL.PRI
| $13.3M | 0.51% |
200,000
| – | – |
|
46
Zimmer Biomet
ZBH
$20.8B
| $13.3M | 0.51% |
102,300
| – | – |
|
47
Sarepta Therapeutics
SRPT
$1.98B
| $13.1M | 0.51% |
+214,100
| New | +$13.1M |
|
|
DHC
48
Diversified Healthcare Trust
DHC
$903M
| $13.1M | 0.5% |
575,054
-95,450
| -14% | -$2.17M |
|
49
Medical Properties Trust
MPW
$2.66B
| $12.4M | 0.48% |
839,217
-81,176
| -9% | -$1.2M |
|
50
CytomX Therapeutics
CTMX
$350M
| $11.9M | 0.46% |
756,090
| – | – |
|